Did Greg Landsman buy Regeneron Pharmaceuticals stock?

Common questions

Did Greg Landsman buy Regeneron Pharmaceuticals stock?

Yes. Greg Landsman disclosed 1 purchase and 1 sale of Regeneron Pharmaceuticals (REGN) stock between Aug 11, 2023 and Oct 15, 2024, in STOCK Act reports. Added together, the disclosed purchases come to $1K-$15K and the disclosed sales to $1K-$15K.

How big were Greg Landsman's Regeneron Pharmaceuticals trades?

STOCK Act reports give a range for each trade, such as $1K-$15K, never an exact amount. Added together, the disclosed purchases come to $1K-$15K and the disclosed sales to $1K-$15K.

Did Greg Landsman make these Regeneron Pharmaceuticals trades personally?

Not always. The STOCK Act requires members to report trades by themselves, a spouse and dependent children. The owner column of each linked filing says whose trade it was.

Does Greg Landsman still own Regeneron Pharmaceuticals stock?

This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.

When did Greg Landsman report these trades?

The latest filing is dated Nov 14, 2024. The STOCK Act gives members of Congress 45 days to report a trade, so a filing can trail the trade by weeks. Every row shows both dates.

Where does this data come from?

From periodic transaction reports filed under the STOCK Act with the Clerk of the House. Every trade links to the original filing.